The latest closing stock price for Edgewise Therapeutics as of May 16, 2025 is 14.78.
An investor who bought $1,000 worth of Edgewise Therapeutics stock at the IPO in 2021 would have $-507 today, roughly -1 times their original investment - a -16.22% compound annual growth rate over 4 years.
The all-time high Edgewise Therapeutics stock closing price was 36.62 on November 06, 2024.
The Edgewise Therapeutics 52-week high stock price is 38.12, which is 157.9% above the current share price.
The Edgewise Therapeutics 52-week low stock price is 10.60, which is 28.3% below the current share price.
The average Edgewise Therapeutics stock price for the last 52 weeks is 23.48.
An investor who bought $1,000 worth of Edgewise Therapeutics stock at the IPO in 2021 would have $-507 today, roughly -1 times their original investment - a -16.22% compound annual growth rate over 4 years.
The all-time high Edgewise Therapeutics stock closing price was 36.62 on November 06, 2024.
The Edgewise Therapeutics 52-week high stock price is 38.12, which is 157.9% above the current share price.
The Edgewise Therapeutics 52-week low stock price is 10.60, which is 28.3% below the current share price.
The average Edgewise Therapeutics stock price for the last 52 weeks is 23.48.